Trial intelligence / Profile preview

Comparing Corneal Wound Healing After Using Sodium Hyaluronate Eye Drops 0.3% and 0.1%

TCTR20210804003Phase 0Not yet recruiting

Sponsor
Research Ethics Committee, Faculty of Medicine, Chiang Mai University
Start
May 2022
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 0 trial of sodium hyaluronate in corneal injury (2 arms), sponsored by Research Ethics Committee, Faculty of Medicine, Chiang Mai University. Primary endpoint: Corneal wound healing. Planned start May 2022; status: not yet recruiting.

02

Drugs

sodium hyaluronate
03

Conditions

corneal injury

Beyond the preview

Go deeper on TCTR20210804003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210804003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call